Hot Products

Hot products from BioCrick which is a professional high-purity natural products manufacturer are well known to scientists around the world because of their high purity and stability. Each product is a chemical compound or substance produced by a living organism—that is, found in nature. In the broadest sense, natural products include any substance produced by life.Natural products remain the best sources of drugs and drug leads, and this remains true today despite the fact that many pharmaceutical companies have deemphasized natural products research in favor of HTP screening of combinatorial libraries during the past 2 decades. From 1940s to date, 131 (74.8%) out of 175 small molecule anticancer drugs are natural product-based/inspired, with 85 (48.6%) being either natural products or derived therefrom. From 1981 to date, 79 (80%) out of 99 small molecule anticancer drugs are natural product-based/inspired, with 53 (53%) being either natural products or derived therefrom. Among the 20 approved small molecule New Chemical Entities (NCEs) in 2010, a half of them are natural products.

Hot products from the professional high-purity natural products manufacturer

Cat.No. Product Name
BCN1857 Rubroside H
1. Rubroside H may show antifungal activity against Aspergillus fumigatus and Candida albicans.
BCN1858 Streptolydigin
1. Streptolydigin has antibacterial activity against a number of Gram positive bacteria. 2. Streptolydigin inhibits RNA polymerase by sequestering the active center in a catalytically inactive conformation.
BCN1859 Tenuazonic acid
1. Tenuazonic acid, an active component in the A. alternata toxin. 2. Tenuazonic acid exhibits a strong inhibition in photosystem II (PSII) activity. 3. Tenuazonic acid causes cell necrosis of host-plants by oxidative damage from chloroplast-mediated ROS eruption, and enhances the plant's resistances against rose aphids.
BCN1860 Tirandalydigin
1. Tirandalydigin is a new tetramic acid antibiotic, it has MICs in the range of 0.5 to 32 micrograms/ml against many pathogenic anaerobes, streptococci, enterococci and legionellae.
BCN1861 Tirandamycin A
1. Tirandamycin A and echinomycin A have anti-amoebic properties, they inhibit the in vitro growth of a E. histolytica laboratory strain (HM-1:IMSS) and a clinical isolate (Colombia, Col) at 30- to 60- uM concentrations. 2. Tirandamycin A and streptolydigin possess potent antibacterial activity particularly against anaerobes, have been shown to inhibit bacterial RNA polymerase.
BCN1862 Tirandamycin B
1. Tirandamycin B is a BmAsnRS inhibitor. 2. Tirandamycin B is a leading anti-filarial drug . 3. Tirandamycin B has antitumor and antibacterial activities.
BCN1863 Vermisporin
1. Vermisporin, a new antibiotic produced by fermentation of the fungus ophiobolus vermisporis. 2. Vermisporin has antimicrobial activity, which MICs for enterobacteriaceae, pseudomonas aeruginosa and haemophilus influenzae exceeds 64 micrograms/ml; which MBCs is 16- to 32-fold above the MICs.
BCN1864 Xanthobaccin A
1. Xanthobaccin A, an antifungal compound, plays a key role in suppression of sugar beet damping-off disease.